The U.S. Department of Justice on Wednesday announced a lawsuit accusing CVS of filling and billing federal health insurance programs for illegal opioid prescriptions.
CVS's stock was headed to its biggest monthly loss in 23 years, as Donald Trump vowed to “knock out” the pharmacy middleman.
CVS Health (CVS) stock price continued its strong downward trend as the company's woes accelerated. Most recently, it has dropped in the last three consecutive weeks, moving to a low of $46.60, its lowest level since March 2020.
Shares of CVS Health Corporation CVS are trading lower on Thursday. This move could break important support.
The pharmacy stock would stand by itself if Walgreens goes private. Wall Street weighs in on the worth of the company's parts.
CVS Health (CVS) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
CVS Health stock price continued to underperform the market this year as the pharmacy industry faced significant challenges. It has dropped by over 30% this year, while the S&P 500 and Nasdaq 100 indices have soared to a record high.
The persistently elevated utilization of medical services is significantly putting pressure on CVS Health's Health Care Benefits segment.
The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price.
CVS Health (CVS) reported earnings 30 days ago. What's next for the stock?
CNBC's Jim Cramer explains why he is keeping an eye on shares of CVS Health.
Shares of healthcare giant CVS Health Corp (NYSE:CVS) are 1.5% higher before the bell, after a bull note at Deutsche Bank.